Details of the Drug

General Information of Drug (ID: DMYDVY4)

Drug Name
BBI-3000
Indication
Disease Entry ICD 11 Status REF
Cutaneous T-cell lymphoma 2B01 Phase 1 [1]
Cross-matching ID
TTD ID
D0M2DM

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)